Lentiviral vectors effectively deliver the gene that encodes coagulation factor IX (FIX) to the liver in dogs with naturally occurring hemophilia B (factor IX deficiency), researchers report in an ...
CD19-targeting UB-VV11 became the first in vivo CAR-T cell therapy to be cleared for human testing by the FDA last year, and ...
Lentiviral vectors have emerged as indispensable tools in gene therapy, offering the ability to integrate therapeutic genes into both dividing and non-dividing cells. Their unique capacity to achieve ...
FA is an inherited syndrome that impairs the body's chromosomal repair systems, causing the bone marrow to lose its ability ...
Verismo Therapeutics, a clinical-stage CAR T company developing a novel KIR-CAR platform technology, today announced the ...
The vector purification market offers significant growth potential due to increasing demand for viral vectors in gene and ...
ProBio recently opened a gene therapy hub in a 128,000-square-foot facility in Mercer County, bringing more than 100 high-skilled jobs to the region. The flagship Cell and Gene Therapy Center of ...
The firm voluntarily retracted the BLA amid an effort to reprioritize its pipeline and is looking for partners to advance the program.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback